![]()
方浩
-
教授
博士生导师
硕士生导师
- 主要任职：山东大学药学院药物化学研究所教授、博士生导师
- 性别：男
- 毕业院校：中国药科大学
- 学历：博士研究生毕业
- 学位：博士生
- 在职信息：在职
- 所在单位：药学院
- 入职时间： 2004-12-23
- 学科：药物化学
- 电子邮箱：phenopro@163.com
访问量：
-
[21]
梁翰之.
Structure-Based Design of 2-Aminopurine Derivatives as CDK2 Inhibitors for Triple-Negative Breast Ca.
FRONT PHARMACOL,
13,
864342,
2022.
-
[22]
汪铃.
Boronate-Based Fluorescent Probes as a Prominent Tool for H2 O2 Sensing and Recognition.
Curr Med Chem,
29,
2476-2489,
2022.
-
[23]
刘蒙.
Strategies to overcome drug resistance using SHP2 inhibitors.
ACTA PHARMACEUTICA SINICA B,
11,
3908,
2021.
-
[24]
Reham M Elhassan.
Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug di.
Medicinal Research Reviews,
42,
1064,
2022.
-
[25]
陈晨.
Discovery of DNA-Targeting HDAC Inhibitors with Potent Antitumor Efficacy In Vivo That Trigger Antit.
Journal of Medicinal Chemistry,
65,
3667,
2022.
-
[26]
梁涛.
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivativ.
European Journal of Medicinal Chemistry,
221,
2021.
-
[27]
梁涛.
Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivativ.
European Journal of Medicinal Chemistry,
221,
2021.
-
[28]
李雯.
Photopharmacology-based small-molecule proteolysis targeting chimeras: optical control of protein de.
Future Medicinal Chemistry,
12,
1991,
2020.
-
[29]
Lu, Wanzhen.
A novel selective histone deacetylase I inhibitor CC-4a activates latent HIV-1 through NF-kappa B pa.
Life Sciences,
267,
2021.
-
[30]
郭永真.
Recent Applications of Benzimidazole as a Privileged Scaffold in Drug Discovery.
Mini-Reviews in Medicinal Chemistry,
21,
1367,
2021.
-
[31]
李雯.
Recent Advances in Small Molecule PROTACs for the Treatment of Cancer.
Current Medicinal Chemistry,
28,
4893,
2021.
-
[32]
赵雲鹏.
Recent Development of Novel HDAC6 Isoform-selective Inhibitors.
Current Medicinal Chemistry,
28,
4133,
2021.
-
[33]
梁涛.
Potential applications of BPFP1 in Bcl-2 protein quantification, carcinoma cell visualization, cell .
European journal of medicinal chemistry,
2021.
-
[34]
李佳.
Synthesis and evaluation of a UMI-77-based fluorescent probe for selective detecting Mcl-1 protein a.
BIOORGANIC & MEDICINAL CHEMISTRY Journal,
29,
2021.
-
[35]
杨越.
Enantioseparation of lysine derivatives on amylose tris (3, 5-dimethylphenylcarbamate) as chiral sta.
Journal of Chromatography A,
1632,
2020.
-
[36]
范颖.
Recent Advances in the Development of Selective Mcl-1 Inhibitors for the Treatment of Cancer (2017-P.
Recent Patents on Anti-Cancer Drug Discovery,
15,
306,
2020.
-
[37]
梁翰之.
Recent progress in development of cyclin-dependent kinase 7 inhibitors for cancer therapy.
EXPERT OPINION ON INVESTIGATIONAL DRUGS,
30,
61,
2021.
-
[38]
杜金童.
An in silico mechanistic insight into HDAC8 activation facilitates the discovery of new small-molecu.
BIOORGANIC & MEDICINAL CHEMISTRY Journal,
28,
2020.
-
[39]
刘璐璐.
Design, synthesis and biological evaluation of tyrosine derivatives as Mcl-1 inhibitors.
European Journal of Medicinal Chemistry,
191,
2020.
-
[40]
杜金童.
Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibi.
Future Medicinal Chemistry,
12,
1293,
2020.
